Harvey RD, Rubinstein WS, Ison G, et al. Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis. ASCO Annual Meeting 2019, abstract LBA108.
Sekseverschillen in ernstige bijwerkingen van immuuntherapie, targeted therapie of chemotherapie
mei 2022 | Immuuntherapie, Leukemie, Longoncologie, Maag-darm-leveroncologie